Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Irritable Bowel Syndrome

• Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).
• Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS
• Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation
• Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
• Tenapanor for the Treatment of Pediatric Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea
• Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
• Ebastine Versus Mebeverine in IBS Patients
• Peppermint Oil for the Treatment of Irritable Bowel Syndrome or Functional Abdominal Pain in Children: the MINT Study
• Efficacy and Safety of DT01 Tablets in Patients With Irritable Bowel Syndrome With Diarrhea
• Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With Bifidice
• Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of IBS-C
• Home Transcutaneous Electrical Acustimulation (TEA)
• Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• FMT for Post-infectious IBS
• A Randomized Single-Blind Controlled Trial Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
• The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With Inflammatory Bowel Syndrome
• Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome
• Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D
• Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease
• Infliximab and Adalimumab in Irritable Bowel Disease Patients.
• Saccharomyces Cerevisiae for Irritable Bowel Syndrome
• Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
• A Phase I Study of ExoFlo, an ex Vivo Culture-expanded Adult Allogeneic Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Isolate Product, for the Treatment of Medically Refractory Crohn's Disease
• Aldafermin (NGM282) for Chronic Diarrhea Due to Bile Acid Malabsorption (BAM)
• Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS)
• The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION)
• Postinfectious Irritable Bowel Syndrome and Gelsectan
• Study of Comparative Effectiveness of Prucalopride and Lubiprostone in Constipation Predominant Irritable Bowel Syndrome
• A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• GI Permeability Change in Response to Aquamin®
• Rifaximin Therapy vs Low FODMAP Diet In IBS
• The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome
• Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
• Effect of Olorinab on Gastrointestinal Transit in Patients With Irritable Bowel Syndrome
• Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth
• SH-DS01 on Fecal Metagenomic Stability
• Probiotics and Irritable Bowel Syndrome
• Efficacy and Safety of Rifaximin With NAC in IBS-D
• Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study
• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen
• Effect of a Probiotic Formula on Reducing SIBO in IBS Patients
• The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme
• Recurrent Abdominal Pain and Exocrine Pancreatic Insufficiency
• Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
• Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention
• Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
• A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Mechanism of PERK - eIF2a Pathways in Intestinal Mucosal Barrier of IBS-D and the Role "Metabolism Ingredients" of Tongxieyaofang
• Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
• Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)
• Olorinab in IBS-C and IBS-D
• Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
• The Efficacy and Safety of "BST104" (Lonicera Flos Extract) in Mild to Moderate Functional Dyspepsia Subjects
• Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome
• Botanical Tincture for Symptoms of Irritable Bowel Syndrome
• Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
• Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
• Efficacy and Safety of SYN-010 in IBS-C
• Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
• Fecal Microbiota Transplantation for Irritable Bowel Syndrome
• Efficacy and Safety of Plecanatide in Children 6 to <18 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C)
• A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
• TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial
• Rifaximin on Visceral Hypersensitivity
• Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome
• Eluxadoline Bile Acid Malabsorption (BAM) Study
• Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
• Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
• Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS)
• Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
• Multi-strain Probiotic in the Management of IBS-D
• Reclassifying Constipation Using Imaging and Manometry
• Study of Performance of Confocal Endomicroscope With Fluorescein Imaging Agent in the Colon
• A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
• A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers
• An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation
• Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
• Ethosuximide to Treat IBS
• Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use
• A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
• A Study of the Effect of Linaclotide on Abdominal Girth in Participants With IBS-C
• Therapeutic Effect of Chang'an I Recipe on Irritable Bowel Syndrome With Diarrhea
• Effects of Open-label vs Double-blind Treatment in IBS
• A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects
• Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
• A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C
• A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers
• Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery
• Long Term Safety Study of Plecanatide
• A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C
• The Effect of Shigyakusan Used for IBS and MUPS Diagnosed by Abdominal N Line Tenderness
• Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea
• Colonoscopy-related Pain Predicts the Treatment Response of Amitriptyline in Patients With Irritable Bowel Syndrome
• A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
• Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome
• Special Drug Use Surveillance of Irribow in Female Patients
• An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
• Pain Relief In Irritable Bowel Syndrome
• Bifidobacteria In Children With Abdominal Pain-Associated Functional Gastrointestinal Disorders
• A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome
• Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
• Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome
• Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
• A Study of the Effect of SYN-010 on Subjects With IBS-C
• Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
• A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C
• Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects
• Efficacy of Open Label Placebo in Children With FGIDs
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
• Safety and Therapeutic Efficacy of Phosphate Enema (Kleen Enema) in Patients Undergoing Sigmoidoscopy
• Clinical Effectiveness of Enteric Coated(E.C.) Anise-oil on Irritable Bowel Syndrome
• Caecal pH as a Biomarker for Irritable Bowel Syndrome
• Pinaverium and Herbs for Irritable Bowel Syndrome Treatment: an Onset and Offset Study (PHIBEST)
• Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
• Confocal Laser Endomicroscopy, IBS and Stress
• Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study
• The Effects of Laxative-probiotic Sequential Treatment in the Irritable Bowel Syndrome Patients
• Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D
• A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically
• Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome
• A Study of Xiang-Sha-Liu-Jun-Zi-Tang in Patients With Irritable Bowel Syndrome
• Use of Novel Prebiotic Fiber for Targeted Dietary Management of Irritable Bowel Syndrome (Nutrabiotix Phase II)
• 52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Ability of Mayo Clinic High-performance Liquid Chromatography (HPLC) Method to Measure Fecal Bile Acids
• 12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)
• Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation
• Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome
• Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
• A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome
• The Effects of Rifaximin Therapy in Irritable Bowel Syndrome
• Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestinal Disease
• Subsensory Sacral Nerve Stimulation for Irritable Bowel Syndrome
• Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo
• The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C)
• Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
• Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial
• A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
• Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
• Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
• Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome
• A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
• Safety and Efficacy Study of GR68755 (Alosetron Hydrochloride) to Treat Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS)
• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Probiotics in the Treatment of Irritable Bowel Syndrome
• Probiotics in the Treatment of Irritable Bowel Syndrome
• Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome
• Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
• A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
• The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
• Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C)
• A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
• Mesalazine Treatment in IBS (The MIBS Study)
• Efficacy of Gralise® for Chronic Pelvic Pain
• Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
• A Randomized, Double-blind, and Placebo-controlled Study on the Treatments of Irritable Bowel Syndrome
• Changes in Gastrointestinal Microbiota Using VSL#3 in Patients With IBS-D
• The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome
• Phase I Clinical Trial of DA-6886 in Healthy Male Subjects
• Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome
• Mode of Action of Moviprep
• The Effect of Neu-P11 on Symptoms in Patients With D-IBS
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
• Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
• Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder
• Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
• Effect of Pentoxifylline on Tight Junctions (TJs) of Intestinal Mucosa in Patients With Irritable Bowel Syndrome(IBS)
• Comparative Efficacy and Safety of Fenoverine
• Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea
• A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
• Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
• Ayurvedic Herbs in Diarrhea Predominant Irritable Bowel Syndrome
• The Effect of Hot Cataplasm With Caraway Oil in the Treatment of Irritable Bowel Syndrome
• Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
• The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
• An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects
• Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)
• Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
• Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial
• A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
• Pregabalin on Colonic Motor and Sensory Function in Constipation Predominant Irritable Bowel Syndrome
• Efficacy of Mesalamine in Diarrhea-predominant Irritable Bowel Syndrome (dIBS)
• Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
• Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)
• A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients
• Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain
• Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome
• Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)
• A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
• Treatment of Abdominal Distension by Biofeedback - a Randomized Controlled Trial
• Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea
• Lubiprostone Effects on Visceral Pain Sensitivity
• Effects of Lubiprostone on Gastrointestinal Transit & pH in Irritable Bowel Syndrome (IBS) With Constipation
• Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)
• Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists
• Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea
• Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
• Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
• Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS)
• A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
• Effects of ROSE-010 on GI Transit in Constipation Predominant Irritable Bowel Syndrome (C-IBS) Patients
• Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syndrome With Predominant Constipation
• Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction
• A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome
• An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
• Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome
• Trial of Chinese Prescription Shugan Decoction on Irritable Bowel Syndrome（Diarrhea Type）
• Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
• Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
• Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial)
• Intestinal Microecology in Chronic Constipation
• The Use of VSL#3 in Irritable Bowel Syndrome in Children
• A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
• Cheno Effect on Transit in Health and IBS-C
• Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?
• Irritable Bowel Syndrome (IBS) Functional Magnetic Resonance Imaging (fMRI) With Desipramine
• Probiotics in Irritable Bowel Syndrome
• Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome
• Constipation Associated With Irritable Bowel Syndrome (IBS-C)
• A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
• Ibodutant for Relief of Irritable Bowel Syndrome (IRIS)
• Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)
• Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Syndrome
• Effect of Bifidobacterium on Irritable Bowel Syndrome
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
• The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) Patients
• An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
• Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)
• Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
• Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)
• Gulf War Digestive Health Study
• The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel Syndrome
• Mesalazine Therapy in Patients With Irritable Bowel Syndrome
• Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
• Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
• Saccharomyces Boulardii in Irritable Bowel Syndrome
• A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome
• SAT vs Escitalopram for Rectal Hypersensitivity
• Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
• Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome
• Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
• Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome
• Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome
• A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation
• A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome
• Citalopram in Irritable Bowel Syndrome
• Sb-705498 Rectal Pain Study
• Diarrhea Predominant Irritable Bowel Syndrome in Females
• Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
• Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome
• Safety and Efficacy of Oral AGN 203818 for the Relief of Irritable Bowel Syndrome Pain
• Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
• Manipulation of Visceral Sensitivity and Immune System in IBS
• A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers
• An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
• A Study of BMS-562086 in Patients With Irritable Bowel Syndrome
• A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
• Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome
• Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation
• Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers
• Study to Assess the Effect Of Alosetron On Mucosal Blood Flow
• The Effect of Probioticson Bloating in IBS
• EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth
• Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
• Effect of Butyrogenic Fibers in IBS Patients
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome
• Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
• Rifaximin for the Treatment of Irritable Bowel Syndrome
• Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS
• DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)
• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c
• A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
• Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)
• Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?
• The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
• The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS)
• Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS
• A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
• Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel Syndrome
• Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)
• Characterization of Pain Processing Mechanisms in Irritable Bowel Syndrome
• Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy
• Brain Imaging and Pain in Irritable Bowel Syndrome
• Treatment of Functional Bowel Disorders